title: Cyclosporin A in treatment of refractory patients with chronic inflammatory demyelinating polyradiculoneuropathy.
authors.affiliation: The Third Department of Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano 390-8621, Japan. matsuda@hsp.md.shinshu-u.ac.jp
authors.forename: Masayuki
authors.initials: M
authors.lastname: Matsuda
authors.forename: Kenichi
authors.initials: K
authors.lastname: Hoshi
authors.forename: Takahisa
authors.initials: T
authors.lastname: Gono
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Morita
authors.forename: Shu-ichi
authors.initials: S
authors.lastname: Ikeda
mesh_terms: D000284:Administration, Oral; D000328:Adult; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D016572:Cyclosporine / Q000627:therapeutic use*; D004185:Disability Evaluation; D004305:Dose-Response Relationship, Drug; D005071:Evoked Potentials / Q000187:drug effects; D005260:Female; D006801:Humans; D008297:Male; D008475:Median Nerve / Q000187:drug effects; D008875:Middle Aged; D018482:Muscle, Skeletal / Q000187:drug effects; D009431:Neural Conduction / Q000187:drug effects; D020277:Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / Q000134:cerebrospinal fluid / Q000188:drug therapy*; D011506:Proteins / Q000378:metabolism; D018709:Statistics, Nonparametric; D013979:Tibial Nerve / Q000187:drug effects; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D018501:Antirheumatic Agents; D011506:Proteins; D016572:Cyclosporine